Delivery Order 36F79719D0217-36C26021F0475
Award Date 6/24/21
Potential Completion Date 9/30/21
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Horsham, PA 19044, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., was awarded a firm fixed-price delivery order valued at $18,803.91 by Veterans Integrated Service Network 5 (VISN 5) on August 6, 2025, with an ultimate completion date of August 7, 2025. The contract covers the delivery of BALVERSA (erdafitinib), a specialized oncology medication, to the Veterans Health Administration facility in Carrollton, Texas. This delivery order carries no set-aside designation and is issued under the...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $15,754 firm fixed price delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Janssen Biotech, Inc. for emergency supplies of Balversa (erdafitinib) 4 mg tablets. Performance will take place in Phoenix, Arizona with an anticipated completion date of August 17, 2022. The award utilizes the GSA Pharmaceuticals and Drugs schedule to procure this oncology...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $17,046 delivery order to Janssen Biotech, Inc. under the company's Pharmaceuticals and Drugs master contract (FSS-61-IB) on the General Services Administration schedule. The order is for BALVERSA RX and has a period of performance from November 24, 2023 through January 23, 2024. The firm fixed price order will be performed in Horsham, Pennsylvania by Janssen Biotech to supply the...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $102,278.90 delivery order to Janssen Biotech, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract. The firm fixed price order is for the delivery of BALVERSA tablets to a location in Carrollton, Texas, with performance required through September 30, 2023. No set-aside provisions were applied to this order for the pharmaceutical products,...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price delivery order to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., for the chemotherapy drug BALVERSA (erdafitinib). This order was placed against Janssen's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, a $3.1 billion multiple award schedule that allows VHA to procure prescription drugs to support veteran healthcare programs. The $22,053.66...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,090.62 delivery order to Janssen Biotech, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The firm fixed price order is for BALVERSA 4MG and has a period of performance through November 6, 2020. No set-aside provisions were applied to this award made to support the VA's healthcare programs. Janssen Biotech will provide the requested pharmaceutical...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $0.00 delivery order to Janssen Biotech, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB). The firm fixed price order is for the delivery of BALVERSA 4MG tablets to a location in Horsham, Pennsylvania, with a completion date of November 9, 2022. No set-aside designation was used for this award made on August 5, 2022 to fulfill pharmaceutical...
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., to provide BALVERSA (erdafitinib), an oncology medication, to the VA's Veterans Health Administration (VHA). The $15,090.62 delivery order was issued on an emergency basis to the pharmaceutical manufacturer under a $3.7 million Blanket Purchase Agreement (BPA) established in 2020, which allows VHA buying offices to efficiently...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,090.88 delivery order to Janssen Biotech, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) for BALVERSA 4 MG. The firm fixed price order is for the delivery of the specified pharmaceutical product to a location in Carrollton, Texas, with performance to be completed by November 13, 2020. No set-aside designation was applied to this order placed...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,090.62 delivery order to Janssen Biotech, Inc. for BALVERSA 4 MG. The contract was issued against the Pharmaceuticals and Drugs Federal Supply Schedule, a multiple award schedule managed by the General Services Administration. Performance will take place in Carrollton, Texas. No set-aside designation was used for this firm fixed price order, which is scheduled for completion by...